Clinical Report: Insights from a Decade of Genetic Variant Reclassification

Overview

A systematic review of 39 studies over the past decade reveals wide variability in genetic variant reclassification rates, ranging from 3.6% to 83.6%. The majority of research focuses on oncology and cardiology, with limited data in endocrinology and obesity, highlighting gaps in variant management practices and the need for standardized reclassification protocols.

Background

Accurate classification of genetic variants is critical for diagnosing hereditary disorders and guiding clinical management. The ACMG/AMP 2015 guidelines categorize variants from benign to pathogenic, but many variants remain of uncertain significance (VUS) due to limited evidence at initial analysis. Variant reclassification is an evolving process reflecting new data from population studies, functional assays, and computational predictions, essential for refining molecular diagnoses and informing patient care.

Data Highlights

Key Findings

• Variant reclassification rates vary widely, influenced by study design and variant types examined.
• Nearly half of the studies specifically addressed variants of uncertain significance (VUS).
• Oncology and cardiology dominate the research landscape; endocrinology and obesity are underrepresented.
• Reclassification methods include literature review, functional assays, in silico pathogenicity predictions, segregation analysis, and machine learning tools.
• Reversals in variant classification (benign to pathogenic or vice versa) are rare but documented.
• Ongoing retrospective reanalyses demonstrate the potential for increased reclassification through routine reinterpretation.

Clinical Implications

Clinicians should recognize that genetic variant classifications are dynamic and may change as new evidence emerges, impacting diagnosis and management. Routine reanalysis and structured protocols for variant reinterpretation and patient recontact are essential to optimize clinical utility. Awareness of the variability in reclassification rates and gaps in certain specialties can guide targeted improvements in genetic counseling and testing strategies.

Conclusion

Variant reclassification is a critical and evolving aspect of genomic medicine, with significant implications for patient care. Standardized guidelines and expanded research across diverse clinical fields are needed to enhance the accuracy and consistency of variant interpretation.

References

1. Reassessing Genetic Variants: A Comprehensive Review, 2025